Neural Therapies is a Contract Research Organization (CRO) created in 2015 as spin-off into the Neurobiology Group of the University of Leon (Spain). The company was initially specialized in performing preclinical studies of drug candidates and/or nutraceuticals as potential therapies in rodent models of stroke, taking advantage of more than ten years of basic and applied research in the field. For six years now, we have been working under three core principles: transparency, cost-efficiency and flexibility. In fact, this latter led us to increase our portfolio based on customer demands, thus offering now a wide range of experimental models in a broad range of pathologies not only within the neuroscience field.
Neural Therapies helps pharmaceutical companies to accelerate preclinical studies, offering full support from the experimental design to the interpretation of the results, always assessed by a panel of experts to optimize costs and assays and customizing each experiment according to the client’s needs.